Summary:
- Cultipharm, a vertical farming technology company based in Mantua, Italy, recently closed a €1M capital increase with backing from AiZei and Moonstone Venture Capital.
- The company plans to use the funds for strategic initiatives across its key operating areas.
- Cultipharm, led by Massimo and Emanuele Lucchini and Alessandro Algeri, specializes in producing and customizing botanicals and active ingredients through vertical farming and advanced research methods.
Article:
Cultipharm Secures €1M Capital Increase for Vertical Farming Technology
Cultipharm, a leading vertical farming technology company headquartered in Mantua, Italy, has successfully completed a €1M capital increase with investment support from AiZei and Moonstone Venture Capital. This funding boost will enable the company to drive strategic initiatives across its key operational areas, further solidifying its position in the industry.
Helmed by the visionary leadership of Massimo and Emanuele Lucchini and Alessandro Algeri, Cultipharm specializes in the production and customization of botanicals and active ingredients utilizing innovative vertical farming techniques. By harnessing cutting-edge research methodologies, including a specialized in-house laboratory, the company leverages plant growth variables to optimize and achieve a reproducible phytochemical profile.
With a focus on sustainability and technological advancement, Cultipharm is paving the way for the future of botanical bio-workshops. By combining expertise in vertical farming with advanced research capabilities, the company is at the forefront of revolutionizing the production systems of tomorrow.
For the latest updates on Cultipharm and the vertical farming industry, stay tuned to FinSMEs for more groundbreaking news and developments.
